TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.

Prithviraj Bose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.